SPONSOR

West China Hospital

Total Trials

Recruiting

Phases

Phase 3, Phase 2, Phase 1, Phase 1, Phase 2

Conditions studied: Lung Neoplasms Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Elderly Locally Advanced Rectal Cancer (LARC)Immunotherapy Radiotherapy Total Neoadjuvant Therapy Anal Function Preservation General Anesthetic

West China Hospital is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Elderly.

The trial portfolio spans Phase 3, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — West China Hospital

How many clinical trials has West China Hospital sponsored?

ClinicalMetric currently tracks 16 clinical trials sponsored by West China Hospital, of which 16 are actively recruiting participants. These trials cover conditions including Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does West China Hospital research focus on?

West China Hospital clinical trials span Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Elderly, Locally Advanced Rectal Cancer (LARC), and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a West China Hospital clinical trial?

To participate in a West China Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all West China Hospital trials with current recruitment status updated daily.

West China Hospital

Frequently Asked Questions — West China Hospital

Clinical Trials by West China Hospital

MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Non-pharmacological Auditory and Somatosensory Stimulation in Anesthetic Emergence

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

Individualized ANH for Non-cardiac Surgery

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I

Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas

Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.

Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients

Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors